Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : sciclone pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Guy Gordon who wrote (479)	3/22/2000 3:41:00 PM
From: Skywatcher	Respond to of 1137

Having the Joe Kernan deal on CNBC really brought out the day traders and rocketed us up into the range we should be in along with real news, this is just more icing on the surprise cakes that this company has in store. Stem cell, CF, Cancer, immuno therapy etc are all icing compared to the potential cash cow of Hep B&C. Chris

To: Guy Gordon who wrote (479)	3/22/2000 3:45:00 PM
From: AurumRabosa	Read Replies (1) \| Respond to of 1137

I don't believe the FDA has approved an NDA for Zadaxin or any other SCLN drug as of yet. They have to successfully complete a Phase III clinical trial and perhaps the FDA will request a Confirmatory Phase III trial as well depending on the trial design and the data. You're absolutely correct that once the FDA has approved a drug for sale in the US for any indication doctors can prescribe it "off-label" for anything they want. This is currently the subject of much debate regarding the abusive use of Ritalin and Prozac prescribed for children 2 to 6 years old. Getting marketing approval for Zadazin for any indication in the US wil be HUGE!!! Orphan Drug Status is granted by the FDA to encourage the development of drugs that treat relatively small markets that might otherwise not attract the attention of Big Pharma. I'm not sure when the 7-year exclusivity clock starts running but I believe it's upon FDA approval of the NDA. Does anyone know for sure?